Changes in recreational drug use, reasons for those changes and their consequence during and after the COVID-19 pandemic in the UK
Comprehensive Psychiatry · 2025-07 · 140 · 152598
DOI: 10.1016/j.comppsych.2025.152598 ↗Kurz gefasst
Fachartikel in der Zeitschrift Comprehensive Psychiatry, 2025-07. Verfasst von Maria Bălăeţ und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Brain Sciences, Imperial College London, London, UK; Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology and Neurosci…. Hauptthemen laut MEDLINE: COVID-19, Substance-Related Disorders, Recreational Drug Use. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South London and Maudsley NHS Foundation Trust, Engineering and Physical Sciences Research Council, King's College London.
Abstract (Originalsprache)
Changes in drug use in the general population during the COVID-19 pandemic and their long-term consequences are not well understood. We employed natural language processing and machine learning to analyse a large dataset of self-reported rates of and reasons for drug use during the pandemic, along with their associations with anxiety, depression and substance use problems post-pandemic. Our findings revealed a transient decrease in drug use at the pandemic's peak, primarily attributed to reduced social opportunities. Conversely, some participants reported increased drug use for self-medication, boredom, and lifestyle disruptions. While users of psychedelics and MDMA had anxiety and depression rates similar to non-users, users of opioid agonists and depressants-representing one in ten active drug users-reported greater mental health challenges post-pandemic. These results suggest that a subset of active drug users with distinct profiles faces elevated risks, particularly for anxiety and depression, and may benefit from targeted support.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Brain Sciences, Imperial College London, London, UK; Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Electronic address: m.balaet1…
- Department of Biology, University of Lund, Sweden.
- Department of Brain Sciences, Imperial College London, London, UK; Division of Psychiatry, Imperial College London, London, UK.
- Department of Psychiatry, Faculty of Medicine, University of Southampton, UK; Southern Health NHS Foundation Trust, Southampton, UK.
- Department of Brain Sciences, Imperial College London, London, UK.
- Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Förderung
- South London and Maudsley NHS Foundation Trust
- Engineering and Physical Sciences Research Council
- King's College London
- Medical Research Council
- National Institute for Health and Care Research
Zitieren
APA
Bălăeţ, M., Zadel, A., Lingford-Hughes, A., Paterson, L. M., Chamberlain, S. R., Trender, W., Hellyer, P. J., & Hampshire, A. (2025). Changes in recreational drug use, reasons for those changes and their consequence during and after the COVID-19 pandemic in the UK. Comprehensive Psychiatry, 140, 152598. https://doi.org/10.1016/j.comppsych.2025.152598
Vancouver
Bălăeţ M, Zadel A, Lingford-Hughes A, Paterson LM, Chamberlain SR, Trender W, et al. Changes in recreational drug use, reasons for those changes and their consequence during and after the COVID-19 pandemic in the UK. Comprehensive Psychiatry. 2025;140:152598. doi:10.1016/j.comppsych.2025.152598
BibTeX
@article{Ble2025,
author = {Bălăeţ, Maria and Zadel, Ana and Lingford-Hughes, Anne and Paterson, Louise M and Chamberlain, Samuel R and Trender, William and Hellyer, Peter J and Hampshire, Adam},
title = {Changes in recreational drug use, reasons for those changes and their consequence during and after the COVID-19 pandemic in the UK},
journal = {Comprehensive Psychiatry},
year = {2025},
volume = {140},
pages = {152598},
doi = {10.1016/j.comppsych.2025.152598}
}
EUVIMED